-Zug, Switzerland, Feb. 24, 2017- Auris Medical Holding AG, a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that the US Food and Drug Administration has granted Fast Track designation for AM-111 in the treatment of acute sensorineural hearing loss.
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week- Baebies, a company focused on advancing newborn screening and pediatric testing, announced it has received de novo clearance from the U.S. Food and Drug Administration for SEEKER. "Although these LSDs have FDA approved therapies, this is a significant milestone for the LSD
Dr Reddys Laboratories has been issued with a Form483 after an inspection at its active pharmaceutical ingredient plant in Miryalaguda in Telangana, India. The site was one of several Dr Reddys facilities criticized in a US FDA warning letter published in 2015.. In addition, the FDA said Dr. Reddys had failed to prevent unauthorized access to quali
HUNTINGTON- Like they have done in other lawsuits against them, wholesale drug distributors accused by Huntington officials of flooding the city with an excess of prescription drugs are requesting the case be tried in federal court rather than a local court. Gregory Donald Chaney, AmerisourceBergen Drug Co., Cardinal Health Inc. and McKesson Corp.
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week The FDA granted EMFLAZA priority review, which is reserved for investigational medicines that may offer major advances in treatment over existing options. "We are pleased to learn that the FDA has approved EMFLAZA," said Pat Furlong, founding President and CEO of Parent Proj
WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for approval of New Animal Drug applications and withdrawal of approval of New Animal Drug Applications:. Where applicable, FDA is also withdrawing approval of those parts of the NADAs that pertain to use of these antimicrobial drugs for prod
WASHINGTON, Feb. 25 The Food and Drug Administration published the following rule in the Federal Register for withdrawal of Approval of a New Animal Drug Application:. Sujaya Dessai, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5761, firstname.lastname@example.org. Putney, Inc., One Monu
Findings from University of Pennsylvania Hospital in the Area of Drug Delivery Systems Described. According to news reporting out of Philadelphia, Pennsylvania, by NewsRx editors, research stated, "Red blood cells are innate carriers that can also be engineered to improve the pharmacokinetics and pharmacodynamics of many drugs, particularly...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases, announced the appointment of Alan Ezekowitz, MBChB, D.Phil., and James J. Collins, Ph.D., to its Board of Directors. Their
Global Weight Loss and Obesity Management Market, by Fitness Equipment (Cardiovascular Training Equipment, Strength Training Equipment, Body Composition Analyzers, Fitness Monitoring Equipment), by Surgical Equipment (Minimally Invasive Surgical Equipment, Non-Invasive Surgical Equipment), by Dietary Supplements, by Services, by Geography Indus
-Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today is reporting additional data from the dose-escalation phase of its ongoing Phase 1/ 2 clinical trial of intratumoral IMO-2125, an agonist of TLR9 in combination with ipilimumab
Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs announced that the Company today received final approval from the U.S. Food and Drug Administration for the Company`s abbreviated new drug...
-Natural Subsistence, a dietary supplement manufacturer that designs a variety of products to improve peoples health and nutrition, announced its product Leyzene now available on StackedNutrition.com, a popular website for nutritional products. Natural Subsistence develops supplements formulated to complement every aspect of health to allow...
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Perrigo Company plc announced that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration for clindamycin, benzoyl peroxide topical gel, the generic version of Onexton gel. Perrigo has notified Valeant Pharmaceuticals North America LLC
Directors from Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce that the two companies have joined forces, resulting in the founding of Pharma To Market Pte Ltd, based in Singapore. Pharma To Market are pleased to announce their expansion into Asia with the opening of an office in Singapore. Joelle and her team will provide support for
By a News Reporter-Staff News Editor at Investment Weekly News Research and Markets has announced the addition of the "Recombinant Drugs to 2020" report to their offering. This report examines FDA and EMA-approved biological drugs and their position and potential in a dozen major disease segments- markets with important implications for drug deve
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Regulus Therapeutics Inc. in the U.S. District Court for the Southern District of California. The complaint is brought on behalf of all purchasers of Regulus securities be
Pomerantz LLP announces that a class action lawsuit has been filed against Egalet Corporation and certain of its officers. The class action, filed in United States District Court, Eastern District of Pennsylvania, is on behalf of a class consisting of investors who purchased or otherwise acquired Egalet securities, seeking to recover compensable
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Regulus Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline RGLS. By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week- Pomerantz LLP announces that a class action lawsuit has been filed against Regulus Therapeutics Inc.
NEW YORK, NY/ ACCESSWIRE/ February 24, 2017/ Pomerantz LLP announces that a class action lawsuit has been filed against TG Therapeutics, Inc. and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17- cv-00508, is on behalf of a class consisting of all persons or entit
Sixty jobs are being created at a Bathgate- based pharmaceutical company. The Bathgate site was originally purpose-built as a clinical packaging and logistics facility and was officially opened by Quintiles in September 1997. Since then it has expanded significantly prior to becoming part of the Catalent network in 2007..
-Doctor C LLC, a company based in Arizona known for its vitamin C supplement The Right C, announced that product will now be available for purchase on StackedNutrition.com, a popular health and nutritional products site. We are pleased to announce that The Right C is now available for sale on StackedNutrition.com, said Travis Lingenfelter, CEO of D
Feb. 25 Two shareholders of Clovis Oncology are accusing the Boulder company of regulatory violations during clinical trials for its failed lung cancer drug rocilentinib,. Clovis disclosed the most recent allegations in a 10- K filed Thursday with the Securities and Exchange Commission, calling them "unfounded." The 10- K filing also reported tha
The STARR Coalition today announced their partnership with Verified Clinical Trials in an ongoing effort to create meaningful change by increasing communication, partnerships and goodwill among stakeholders in the areas of treatment, advocacy, and pharmaceutical research with emphasis on consumers and patients' mental health well-being.
Dublin- Research and Markets has announced the addition of the "Pulmonary/ Respiratory Drug Delivery Market by Formulation, Canister, End User, Applications- Forecasts to 2021" report to their offering. Presently, North America dominates the pulmonary drug delivery market, and Europe represents the second-largest regional market. This is attributed